South China Morning Post CENTER (0.0) Reliability: 7.5/10

Mainland China’s investors pour into Hong Kong-listed drug stocks, riding licensing wave

✍️ Julie Zhang 📅 February 10, 2026 05:00 AM ⏱️ 1 min read 🕐 Scraped: February 10, 2026

Summary: An index tracking Stock Connect buying of 40 mainland drug firms gains 9 per cent in a week as China’s industry heft grows.

Investors in mainland China raised their stakes in Hong Kong-listed drug makers through the cross-border trading link over the past week, as a wave of out-licensing deals between the country’s pharmaceutical firms and global partners rol

📰

Continue Reading on South China Morning Post

This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.

Read Full Article →

How do you feel about this article?

Read Original Article →

📝 Article Information

Author

Julie Zhang

Original Publisher

🌍 South China Morning Post

CENTER Bias (0.0)

Published Date

February 10, 2026 at 05:00 AM

ℹ️

Disclaimer

ArkforgeAI.com - Newsource is a news aggregation platform. We do not create, write, or produce original news content. All articles are sourced from their respective publishers and remain the property of their original creators. We analyze and aggregate news from multiple sources to provide diverse perspectives across the political spectrum.

The content displayed here is for informational purposes only. For the complete and original article, please visit the source's website using the "Read Original Article" link above.